A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hit

TD Cushing, V Baichwal, K Berry, R Billedeau…

Index: Bioorganic and Medicinal Chemistry Letters, , vol. 21, # 1 p. 417 - 422

Full Text: HTML

Citation Number: 7

Abstract

... Bioorganic & Medicinal Chemistry Letters. ... a Medicinal Chemistry, Amgen Inc., 1120 ... d Pharmacokinetics and Drug Metabolism, Amgen Inc., 1120 Veterans Blvd., South San Francisco, CA 94080, USA; e Chemistry, Roche Palo Alto, Hillview Ave., Palo Alto, CA 94304, USA; ...

Anti-mutagenic structural modification by fluorine-substitution in highly mutagenic 4-methylquinoline derivatives

[Kato, Taka-Aki; Hakura, Atsushi; Mizutani, Takaharu; Saeki, Ken-Ichi Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 2000 , vol. 465, # 1-2 p. 173 - 182]

A facile synthesis of novel 9-methyl [1, 2, 3] selenadiazoles [4, 5-b] quinoline and 9-methyl [1, 2, 3] thiadiazole [4, 5-b] quinoline as a new class of antimicrobial agents

[Phosphorus, Sulfur and Silicon and the Related Elements, , vol. 181, # 3 p. 533 - 541]

A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hit

Abstract

Related Articles:

More Articles...